<DOC>
	<DOCNO>NCT01355172</DOCNO>
	<brief_summary>The purpose study evaluate antibody response three influenza vaccine strain include seasonal flu vaccine ( AdimFlu-S ) , measure hemagglutination inhibition ( HAI ) 4 week two dos study vaccine , 4 week apart , infant 6 12 month age .</brief_summary>
	<brief_title>Immunogenicity Safety AdimFlu-S , Formulation 2010-2011 , Infants Aged Between 6-12months Old</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Boys girl age &gt; = 6 month old &lt; = 12 month old day first vaccination ; Subject 's parent ( ) legal guardian ( ) must willing comply plan study procedure available study visit ; Subject must good physical health basis medical history , physical examination ; Subject 's parent ( ) legal guardian ( ) must read sign studyspecific inform consent prior initiation study procedure . Subjects received influenza vaccine ; History hypersensitivity egg egg protein similar pharmacological effect study medication ; Personal family history Guillain Barre ' Syndrome ; An acute febrile illness within 1 week prior vaccination ; Current upper respiratory illness ( URI ) , include common cold nasal congestion within 72 hour ; Subjects influenzalike illness define presence fever ( temperature &gt; = 38 ' C ) least two follow four symptom : headache , muscle/joint ache pain ( e.g . myalgia/arthralgia ) , sore throat cough ; Treatment investigational drug device , participation clinical study , within 3 month consent ; Immunodeficiency , immunosuppressive significant chronic illness suitable inactivated influenza vaccination ; History wheeze bronchodilator use within 3 month prior study vaccine ; Receipt live virus vaccine within 1 month prior study vaccine expect receipt vaccination last blood sample immunogenicity evaluation ; Receipt inactivate vaccine within 2 week prior study vaccination expect receipt vaccination last blood sample immunogenicity evaluation ; Receipt blood product , include immunoglobulin prior 3 month ; Underlying condition investigator ' opinion may interfere evaluation vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Immunogenicity</keyword>
</DOC>